Oncology Professor in United Kingdom
Justin trained at Trinity College, Oxford earning a first-class degree. He undertook a medicine residency at Johns Hopkins Hospital, USA, then continuing at The Royal Marsden, St Bart's Hospitals. He was from 2009-2022 Professor of Oncology at Imperial College. He has published over 650 peer-reviewed papers with an h-index of 86. The charity Action Against Cancer supports him.
He is a Fellow of the Royal College of Physicians, the Royal College of Pathologists and sits on many advisory boards. His team published in Nature Medicine the discovery of a new cancer-causing gene. Recent papers include use of biosimilars, increasing access across the developing world.
At the pandemic's start, Justin published pieces in the Lancet using artificial intelligence to find a new drug. His work on mechanistic studies and trials helped gain FDA approval for hospitalised patients with the highest mortality benefit. Justin's book ‘Witness to Covid’ describes this, with a foreword by Sid Mukherjee, a joint lecture here. In 2022 he resigned from Imperial, became Visiting Professor and a Professor at ARU, Cambridge with active research programs.